FR2346337A1 - Derives d'uracil, leur procede de preparation et leur application pharmacologique - Google Patents

Derives d'uracil, leur procede de preparation et leur application pharmacologique

Info

Publication number
FR2346337A1
FR2346337A1 FR7709280A FR7709280A FR2346337A1 FR 2346337 A1 FR2346337 A1 FR 2346337A1 FR 7709280 A FR7709280 A FR 7709280A FR 7709280 A FR7709280 A FR 7709280A FR 2346337 A1 FR2346337 A1 FR 2346337A1
Authority
FR
France
Prior art keywords
preparation
uracil derivatives
pharmacological application
pharmacological
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7709280A
Other languages
English (en)
Other versions
FR2346337B1 (fr
Inventor
Osamu Miyashita
Koichi Matsumura
Hiroshi Shimadzu
Naoto Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3665376A external-priority patent/JPS52118480A/ja
Priority claimed from JP12993276A external-priority patent/JPS5353672A/ja
Priority claimed from JP14679576A external-priority patent/JPS5371086A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2346337A1 publication Critical patent/FR2346337A1/fr
Application granted granted Critical
Publication of FR2346337B1 publication Critical patent/FR2346337B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7709280A 1976-03-31 1977-03-29 Derives d'uracil, leur procede de preparation et leur application pharmacologique Granted FR2346337A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3665376A JPS52118480A (en) 1976-03-31 1976-03-31 Synthesis of uracil derivatives
JP12993276A JPS5353672A (en) 1976-10-27 1976-10-27 Fluoropyrimidine deivatives
JP14679576A JPS5371086A (en) 1976-12-06 1976-12-06 Preparation of uracil derivs.

Publications (2)

Publication Number Publication Date
FR2346337A1 true FR2346337A1 (fr) 1977-10-28
FR2346337B1 FR2346337B1 (fr) 1983-05-13

Family

ID=27289176

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7709280A Granted FR2346337A1 (fr) 1976-03-31 1977-03-29 Derives d'uracil, leur procede de preparation et leur application pharmacologique

Country Status (18)

Country Link
US (1) US4329460A (fr)
CA (1) CA1081226A (fr)
CH (1) CH632748A5 (fr)
DD (2) DD137353A5 (fr)
DE (1) DE2714392A1 (fr)
DK (1) DK142029B (fr)
ES (1) ES469098A1 (fr)
FI (1) FI770904A (fr)
FR (1) FR2346337A1 (fr)
GB (1) GB1546346A (fr)
GR (1) GR68935B (fr)
NL (1) NL7703541A (fr)
NO (1) NO771124L (fr)
PH (1) PH14553A (fr)
PL (1) PL106917B1 (fr)
PT (1) PT66374B (fr)
SE (1) SE7703721L (fr)
SU (1) SU795467A3 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179188A (en) * 1981-04-28 1982-11-04 Shionogi & Co Ltd 5-fluorouracil derivative
DK167280B1 (da) * 1985-03-20 1993-10-04 Ciba Geigy Ag 3-aryluracilderivater, fremgangsmaade til fremstilling deraf, ukrudtsbekaempelsesmidler indeholdende disse derivater samt anvendelsen af derivaterne til ukrudtsbekaempelse
US4669081A (en) * 1986-02-04 1987-05-26 Raytheon Company LSI fault insertion
US4816585A (en) * 1987-03-05 1989-03-28 Olin Corporation Tetraalkylpiperidinyl substituted uracil derivatives and their use as ultraviolet light stabilizers
US4904714A (en) * 1987-10-02 1990-02-27 Olin Corporation Synthetic resin composition and its method of use
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
US5312919A (en) * 1992-06-12 1994-05-17 Baylor Research Institute Photooxidation products and derivatives thereof of merocyanine-540, their preparation and uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277092A (en) * 1963-05-02 1966-10-04 Hoffmann La Roche 5, 6-substituted dihydro-5-fluoropyrimidines
US3221010A (en) * 1963-05-02 1965-11-30 Hoffmann La Roche 5,6-substituted dihydro-5-fluoropyrimidine nucleosides
US3201387A (en) * 1963-09-18 1965-08-17 Heidelberger Charles 5-trifluoromethyluracil, derivatives thereof, and processes for preparing the same
US3360523A (en) * 1964-06-17 1967-12-26 Du Pont 3, 5, 6-substituted hydrouracils
US3406023A (en) * 1966-10-31 1968-10-15 Du Pont Herbicidal method
US3954758A (en) * 1970-05-27 1976-05-04 Pcr, Inc. Process for fluorinating uracil and derivatives thereof
CH553195A (de) * 1971-03-19 1974-08-30 Sandoz Ag Verfahren zur herstellung neuer 2,6-dichlor-benzaldoximo-(s-triazinyl-(6))-aether.
US3987045A (en) * 1971-05-03 1976-10-19 Basf Aktiengesellschaft Disperse dyes based on isoindolene derivatives
US3954759A (en) * 1972-07-13 1976-05-04 Pcr, Inc. Process for preparation of 6-substituted 5-fluorouracil derivatives
DE2401619C2 (de) * 1974-01-14 1986-04-03 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Fungistatisch wirksame Uracilderivate und Verfahren zu ihrer Herstellung
FR2298332A1 (fr) * 1975-01-22 1976-08-20 Asahi Chemical Ind Nouveaux derives de 5-fluorouraciles
US4071519A (en) * 1975-11-05 1978-01-31 Mitsui Toatsu Chemicals, Incorporated 1-Carbamoyl-5-fluorouracil derivatives
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
PT66374B (en) 1978-08-25
DK142029C (fr) 1981-01-05
PH14553A (en) 1981-09-24
DD137353A5 (de) 1979-08-29
CA1081226A (fr) 1980-07-08
FR2346337B1 (fr) 1983-05-13
PT66374A (en) 1977-04-01
NO771124L (no) 1977-10-03
GR68935B (fr) 1982-03-29
DE2714392A1 (de) 1977-12-22
PL197045A1 (pl) 1978-02-13
FI770904A (fr) 1977-10-01
DD132790A5 (de) 1978-11-01
NL7703541A (nl) 1977-10-04
ES469098A1 (es) 1979-09-16
US4329460A (en) 1982-05-11
DK142029B (da) 1980-08-11
SE7703721L (sv) 1977-10-01
GB1546346A (en) 1979-05-23
PL106917B1 (pl) 1980-01-31
SU795467A3 (ru) 1981-01-07
DK141177A (fr) 1977-10-01
CH632748A5 (de) 1982-10-29

Similar Documents

Publication Publication Date Title
BE849794A (fr) Derives de carbostyrile et leur procede de preparation
FR2555585B1 (fr) Derives de la 1-heteroaryl-4 ((2,5-pyrrolidinedion-1-yl) alkyl )piperazine, leur procede de preparation et leur application pharmacologique
BE850401A (fr) Derives de phtalane et procede de preparation
LU78861A1 (fr) Procede de preparation de nouveaux derives steroides 4,9-dieniques 11beta-substitues
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
FR2571052B1 (fr) Derives de 1,3-oxazolidine-2-one et leur procede de preparation
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
BE842811A (fr) Derives d'eburnamenine, leur procede de preparation et leurs applications
FR2346337A1 (fr) Derives d'uracil, leur procede de preparation et leur application pharmacologique
BE855218A (fr) Derives de benzodioxol, leur procede de preparation et leur utilisation
FR2353537A1 (fr) Nouveaux derives aminomethylazoliques, leur procede de preparation et l
BE844229A (fr) Nouveaux derives d'apovincaminol leur procede de preparation et leur application
BE855121A (fr) Derives d'uracile et procede pour leur preparation
BE859081A (fr) Derives de l'anthraquinone et leur procede de preparation
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
BE851681A (fr) 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
BE895213A (fr) Derives d'azolyl-pentene, leur procede de preparation et leur utilisation
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique
BE848627A (fr) Derives substitues d'aminobenzaldehydes et leur procede de preparation,
BE862095A (fr) Derives de l'imidazole, leur procede de preparation et leur application
BE849570A (fr) Derives d'uree, leur procede de preparation et leur utilisation
BE852700R (fr) Procede de preparation d'oxaphospholannes-1,2
FR2352830A1 (fr) Derives de la neamine et leur procede de preparation
FR2338942A1 (fr) Derives de 1,3-dihydro-1'-dimethylphosphinylalkyl-3-phenylspiro (isobenzofuranne-cycloazalcanes), leur procede de preparation et leur application
FR2344535A1 (fr) 2-oxo-1-pyrrolidines et leur procede d'obtention

Legal Events

Date Code Title Description
ST Notification of lapse